DC
Defender Capital Portfolio holdings
AUM
$295M
This Quarter Return
+1.85%
1 Year Return
+53.43%
3 Year Return
+101.94%
5 Year Return
+160.32%
10 Year Return
–
AUM
$291M
AUM Growth
+$291M
(+1.6%)
Cap. Flow
+$3.92M
Cap. Flow
% of AUM
1.35%
Top 10 Holdings %
Top 10 Hldgs %
91.27%
Holding
41
New
2
Increased
12
Reduced
13
Closed
4
Top Buys
| 1 |
Vanguard Short-Term Treasury ETF
VGSH
|
$5.77M |
| 2 |
Fortive
FTV
|
$1.64M |
| 3 |
STAAR Surgical
STAA
|
$1.36M |
| 4 |
Teledyne Technologies
TDY
|
$664K |
| 5 |
Pfizer
PFE
|
$658K |
Top Sells
| 1 |
Monster Beverage
MNST
|
$2.29M |
| 2 |
Berkshire Hathaway Class B
BRK.B
|
$1.3M |
| 3 |
Axon Enterprise
AXON
|
$896K |
| 4 |
Alphabet (Google) Class A
GOOGL
|
$605K |
| 5 |
Enovis
ENOV
|
$577K |
Sector Composition
| 1 | Healthcare | 25.07% |
| 2 | Technology | 19.02% |
| 3 | Financials | 15.39% |
| 4 | Consumer Staples | 9.24% |
| 5 | Industrials | 5.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Vanguard Short-Term Treasury ETF
VGSH
$22.9B
| $69.5M | 23.9% | 1,204,145 +99,975 | +9% | +$5.77M |
|
|
2
Berkshire Hathaway Class B
BRK.B
$1.09T
| $44.2M | 15.21% | 129,764 -3,819 | -3% | -$1.3M |
|
3
Danaher
DHR
$147B
| $34.6M | 11.89% | 144,082 +1,383 | +1% | +$332K |
|
|
4
Fortive
FTV
$16.2B
| $30M | 10.32% | 401,398 +21,902 | +6% | +$1.64M |
|
|
5
STAAR Surgical
STAA
$1.36B
| $27.2M | 9.35% | 517,352 +25,855 | +5% | +$1.36M |
|
|
6
Monster Beverage
MNST
$60.9B
| $17.4M | 5.98% | 302,667 -39,913 | -12% | -$2.29M |
|
|
7
Teledyne Technologies
TDY
$25.2B
| $14.7M | 5.05% | 35,707 +1,615 | +5% | +$664K |
|
|
8
Axon Enterprise
AXON
$58.7B
| $11.4M | 3.93% | 58,557 -4,590 | -7% | -$896K |
|
9
Costco
COST
$418B
| $9.22M | 3.17% | 17,130 +505 | +3% | +$272K |
|
10
Lineage Cell Therapeutics
LCTX
$267M
| $7.2M | 2.48% | 5,109,710 -26,375 | -0.5% | -$37.2K |
|
11
Palantir
PLTR
$372B
| $5.18M | 1.78% | 337,540 +13,210 | +4% | +$203K |
|
12
Intel
INTC
$107B
| $2.73M | 0.94% | 81,715 -3,100 | -4% | -$104K |
|
13
Bloom Energy
BE
$12.4B
| $2.61M | 0.9% | 159,300 +6,500 | +4% | +$106K |
|
14
ESAB
ESAB
$7B
| $2.47M | 0.85% | 37,075 -948 | -2% | -$63.1K |
|
15
ANI Pharmaceuticals
ANIP
$2.03B
| $1.29M | 0.44% | 24,000 | – | – |
|
16
Microsoft
MSFT
$3.77T
| $1.12M | 0.38% | 3,286 -93 | -3% | -$31.7K |
|
17
Apple
AAPL
$3.45T
| $980K | 0.34% | 5,053 -2,129 | -30% | -$413K |
|
18
Chevron
CVX
$324B
| $944K | 0.32% | 6,005 -995 | -14% | -$156K |
|
19
Lifecore Biomedical
LFCR
$285M
| $836K | 0.29% | 86,450 | – | – |
|
20
Amazon
AMZN
$2.44T
| $665K | 0.23% | 5,100 +140 | +3% | +$18.3K |
|
|
21
Pfizer
PFE
$141B
| $658K | 0.23% | +17,935 | New | +$658K |
|
22
iShares Russell 2000 ETF
IWM
$67B
| $581K | 0.2% | 3,100 | – | – |
|
23
Horizon Kinetics Inflation Beneficiaries ETF
INFL
$1.27B
| $556K | 0.19% | 18,200 | – | – |
|
|
IMDX
24
Insight Molecular Diagnostics Inc. Common Stock
IMDX
$72.4M
| $535K | 0.18% | 2,327,930 -35,500 | -2% | -$8.16K |
|
25
iShares Core S&P 500 ETF
IVV
$662B
| $525K | 0.18% | 1,179 | – | – |
|